SCHEMBL23658699

SCHEMBL23658699

Cc1cncc2c1NC(=O)C(C)(C)N2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MOGAT2 Q3SYC2 2/20 0.31
▸ MGAT2 Q10469 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23648003 0.81 MOGAT2 (0.34) MOGAT2
SCHEMBL23648098 0.79 — —
SCHEMBL21624172 0.73 AKR1B1 (0.43) —
SCHEMBL21624113 0.70 MOGAT2 (0.40) MOGAT2
SCHEMBL21636537 0.68 MOGAT2 (0.46) MOGAT2
SCHEMBL19366887 0.66 — —
SCHEMBL3595402 0.62 BRD4 (0.37) MGAT2
SCHEMBL23648086 0.61 — —
SCHEMBL21624341 0.61 MOGAT2 (0.38) MOGAT2
SCHEMBL23647755 0.61 MOGAT2 (0.38) MOGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090661-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
WO-2021144440-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
Send feedback